AESARA Welcomes Industry Veteran Anita Brogan as VP of Modeling and Communications
AESARA, a leading digital-forward Value & Access agency, today announced the appointment of Anita Brogan, PhD, as Vice President, Value & Evidence - Modeling and Communications within its Value and Evidence team. With over 20 years of experience designing and building economic analyses to support value assessment and patient access for innovative healthcare interventions, Anita brings deep expertise in both global and country-specific modeling approaches.
AESARA Welcomes Industry Veteran Andy Fuller as VP of Market Access
AESARA, a leading digital-forward Value & Access agency, is pleased to announce the appointment of Andy Fuller as Vice President of US Market Access within its Strategic Partnerships team. With over 27 years of experience in the pharmaceutical industry, Fuller brings extensive expertise in developing and executing go-to-market and payer engagement strategies across highly competitive markets.
Pharmaceutical Industry Medical Affairs and Market Access Veteran John Byrd, PhD, MBA to Join AESARA as VP, Management Consulting
We are pleased to announce the appointment of John Byrd as VP, Management Consulting at AESARA, a digital-forward Value & Evidence agency that develops innovative and trusted solutions to power transformative market access.
AESARA, INC. Has Successfully Met Standards as a Women’s Business Enterprise and Minority Supplier
AESARA, INC. is pleased to announce its recent certifications by the Women’s Business Enterprise National Council (WBENC) and National Minority Supplier Development Council (NMSDC).
Expansion of AESARA's Management Consulting and Market Access Services With the Appointment of Erin McInerney-Prichard
Market Access and Management Consulting business development veteran Erin McInerney-Prichard to join Strategic Partnerships team as VP, Management Consulting at AESARA, a digital-forward market access agency that develops innovative and trusted solutions to power transformative market access.
Life Sciences Business Development Veteran Pamela Read to Head Business Development and Operations (BDO) at AESARA.
To support the ambition and growth of AESARA, a new function within the organization has been created. Ruslan Horblyuk, Chief Strategic Consulting Officer of AESARA, said, "After nearly 5 years at AESARA, Pam is stepping up to take on a business-critical role as the Head of BDO to help fuel our growth in 2023 and beyond. Over the years, Pam’s contributions to continuous improvement in the business development discipline and operational efficiency make her a perfect candidate to lead this newly formed business critical team.”
Pharma Veteran, Academician and Researcher Cristina Masseria, PhD, MSc to be Head of the Value and Evidence Team at AESARA
AESARA welcomes Cristina Masseria to AESARA bringing over 20 years of experience that spans across multiple therapy areas, research methods, innovation, and corporate leadership further expanding AESARA’s growth.
Pharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology.
AESARA is pleased to announce the appointment of Rohit Borker as VP, Oncology, at AESARA, a digital-forward market access agency that develops innovative and trusted solutions to power transformative market access.
Expansion of AESARA Europe with the Appointment of Market Access Expert, Sameera Tak
AESARA (www.aesara.com) is pleased to announce the appointment of experienced industry market access executive Sameera Tak, MSc, to the European Strategic Partnerships team.
AESARA to welcome the incoming class of five fellows and a visiting scientist.
AESARA is pleased to announce the new entrants to its two-year Doctor of Pharmacy fellowship program, Denise Garner, PharmD, Ashik Jayakumar, PharmD, Fadi Manuel, PharmD and Amanda Pan, PharmD. Denise and Ashik are joining AESARA as part of the Market Access and Health Informatics Fellowship Program between University of North Carolina and AESARA; Fadi and Amanda mark the first generation of the AESARA PAIDEIA Fellowship Program.
AESARA, Inc. to Expand European Presence into Zug, Switzerland
AESARA (www.aesara.com) is pleased to announce expansion of its European operations by establishing a new hub in Zug, Switzerland, in May 2022.
AESARA, Inc. to Present New Health Economics and Outcomes Research (HEOR) Data at the 2022 Annual Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR)
AESARA (www.aesara.com) is pleased to announce their attendance and poster presentations this ISPOR 2022 held in Washington, D.C. from May 16 – 18, 2022. A total of six posters will be presented by the AESARA team and collaborators, focusing on health economic and outcome research (HEOR) topics.
Pharmaceutical Industry Veteran Chad Patel to Lead US Strategic Partnerships for AESARA, Inc.
AESARA is pleased to announce the return of Chad Patel to the AESARA team (www.aesara.com). "Chad represents a new breed of Life Sciences industry executives with extensive field experience coupled with health ecosystem and business acumen, who has a proven track record of success, a vision and an ability to transform the market access agency services to support the transition from volume- to value-based health care services delivery,” said Sissi Pham, CEO of AESARA.
